ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Intersect ENT Inc

Intersect ENT Inc (XENT)

28.25
0.00
(0.00%)
Cerrado 13 Diciembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
28.25
Postura de Compra
28.16
Postura de Venta
28.36
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
28.25
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

XENT Últimas noticias

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare...

Intersect ENT Reports Third Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter...

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc. PR Newswire NEW YORK, Aug. 9, 2021 NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating...

Intersect ENT Reports Second Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the second quarter...

Medtronic to Acquire Intersect ENT

Medtronic to Acquire Intersect ENT Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio PR Newswire DUBLIN and MENLO PARK, Calif., Aug. 6, 2021...

U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

VenSure and Cube Join the Company’s Portfolio of Localized Drug Delivery Creating an Integrated Offering of ENT Technologies to Treat CRS Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose...

Intersect ENT to Report Second Quarter 2021 Financial Results on August 6

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that it will release second quarter...

Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced preliminary second quarter 2021 revenue...

Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus...

Localized steroid-releasing sinus implant designed to maintain sinus opening now available in select EU countries Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SHOTWSafety Shot Inc
US$ 0.25
(79.21%)
29.07k
PALIPalisade Bio Inc
US$ 2.36
(68.57%)
68.2M
LAESSEALSQ Corporation
US$ 1.8401
(60.01%)
256.79M
HIMXHimax Technologies Inc
US$ 9.73
(45.22%)
20.06M
TRVITrevi Therapeutics Inc
US$ 3.60
(44.58%)
63.85M
SPGCSacks Parente Golf Inc
US$ 0.3621
(-74.14%)
29.71M
KROSKeros Therapeutics Inc
US$ 18.40
(-73.20%)
14.65M
TFFPTFF Pharmaceuticals Inc
US$ 0.0657
(-59.62%)
13.29M
SFHGSamfine Creation Holdings Group Ltd
US$ 1.27
(-58.36%)
7.38M
APVOAptevo Therapeutics Inc
US$ 5.60
(-44.06%)
6.49M
GOEVCanoo Inc
US$ 0.1737
(33.62%)
970.8M
LAESSEALSQ Corporation
US$ 1.8401
(60.01%)
256.79M
NVDANVIDIA Corporation
US$ 137.34
(-1.41%)
159.23M
RGTIRigetti Computing Inc
US$ 5.9591
(-19.25%)
158.72M
CDTConduit Pharmaceuticals Inc
US$ 0.0798
(-9.63%)
119.28M
eur06 eur06 8 minutos hace
Very happy for you dino.
I’m waiting for new funds but satisfied with what I have already.
VCNX
VCNX
StockDetective StockDetective 11 minutos hace
https://www.credexcorporation.com/CREDEX%20CORPORATION--Letter%20from%20Chairman--12-12-2024.pdf
AMMJ
Tesla Trillionaire Tesla Trillionaire 15 minutos hace
Trump to transition USPS vehicle to Tesla EVs. 

A $10B program to buy EVs for the U.S. Postal Service is far behind schedule, with defense contractor Oshkosh not disclosing significant manufacturing difficulties for more than a year.

The USPS has received only 93 trucks
TSLA
bluebird50 bluebird50 16 minutos hace
Your obviously dealing with a pain many have felt before... so liberate yourself!!! 
Money is just a tool!! Not an object worthy of veneration on a sacred level... when you've accomplished that? You become objective! And when your objective? You see things much clearer!!! 
So first off
HMBL
Elroy Jetson Elroy Jetson 19 minutos hace
The Mad Rabbit Warren
https://www.siliconinvestor.com/public/4188495_157dda1623b70d90e63083148a85d764.jpg
https://www.siliconinvestor.com/public/4188495_c7fa650acdb800d97c087005bb87687e.jpg
Kettilbjorn Kettilbjorn 22 minutos hace
Historical placebo group decline rates aren't gonna be the key comparison here. I think the more informative measure will be annual rate of decline - does the OLE treated group show a similar rate to yr 1 over years 2+ and does the switch to placebo group show a similar somewhat "reduced" rate of d
AVXL
EpicNavigator33 EpicNavigator33 22 minutos hace
Slowly building this time so hopefully the price won’t just give out from under it this time
HMBL
dalesio_98 dalesio_98 29 minutos hace
To reiterate ...

"If you require documents for whatever reason, contact the law firm and pay the necessary fee or request them from the court record or go view the court record yourself and obtain copies. Do your DD."

[...]

https://investorshub.advfn.com/
boi568 boi568 31 minutos hace
I'm so hyped that I'm thinking Doc may now think blarcamesine has a three percent chance of EMA approval.
AVXL
Ashley250nelson Ashley250nelson 33 minutos hace
/Down 27% today! going to zero
VAPR
jog49 jog49 33 minutos hace
"Knowing our luck we will be in the 3.2% camp."

My very thought! LOL!
FNMA
Vexari Vexari 34 minutos hace
Exploding onto a scene

Before one is ready

Is a learning process

Waiting to happen
primewa primewa 43 minutos hace
Abolish CFPB and FHFA on the horizon by the Trump agenda project 2025. The two agencies are wasting taxpayers money and abusing power. F&F will liberate one and for all back to private SH and MAGA. Can't wait for it.

https://www.bhfs.com/insights/alerts-articles/2024/cfpb-and-fhfa-on-
FNMA
dc key dc key 47 minutos hace
From 4-28-24 news release, Multi Year PCAOB Audit - "The importance of completing a PCAOB audit cannot be understated," commented CEO, Nils Ollquist. I guess the hardest question to answer is when ?
BMXI
jaiguruji7 jaiguruji7 47 minutos hace
Hey Stuck Barbara did you just shi-***t your pants. Why are u concerned you want the share price to go down you naked short minion right right. Those were the orders from your naked short Kramer Bosses. Right Right ?JMHO
DBMM
MrLWLG101 MrLWLG101 48 minutos hace
Thank you for sharing your interpretation and line of reasoning, outlining what could be considered a worst-case scenario, where every element is staged and part of a fictional narrative. In such a case, we wouldn't be discussing a company anymore but rather an outright fraud. I assume that the new
LWLG
jeunke22 jeunke22 52 minutos hace
Thanks for some truly great posts. Just to add my perspective: the term ‘strategic partner’ was for the first time used by Lebby some time ago on the website accompanying a new promotional video. Now the term has been used again in the latest PR announcing the organizational changes,
It seem
AMD
rx7171 rx7171 54 minutos hace
No mention but it would be logical to include gathering that data since to me a huge positive that anyone can understand.
AVXL
jimmy051357 jimmy051357 56 minutos hace
Is DNAX still involved with SANP?
DNAX SANP
uber darthium uber darthium 56 minutos hace
Be thankful this scam isn’t SHMP aka NaturalShareSellingScams in receivership.

GRPS could be worse and is in far better shape than NaturalShareSellingScams


Noted and GRPS Correct
GRPS SHMP
satter satter 1 hora hace
You realize I am sure, it's not real. It's fairytale delusional tales pulled from the conspiracy encyclopedias where evidence, proof, and or facts don't exist, instead are replaced by fake, bogus, laughable loony tune thoughts.
ShawnP123 ShawnP123 1 hora hace
Something to think about. Below is the basic earnings for Broadcom

Earnings per share: $1.42, adjusted vs. $1.38 expected
Revenue: $14.05 billion vs. $14.09 billion expected
Broadcom said it expects first-quarter revenue of about $14.6 billion, just ahead of the
NVDA

Su Consulta Reciente

Delayed Upgrade Clock